SMART IMMUNE
Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change prognosis and life quality for patients with devastating diseases. The company first cell therapy program is based on T cell progenitors or ProTcellsTM (CD7+/CD34- ; CD5- cells) curative power to enable a short, polyclonal and safe post transplantation immune recovery. This program be completed by integrative developments from targeted conditioning to gene therapy and genome editing enabling clinicians to access new generation treatments for a wide variety of inherited blood disorders and blood cancers.
SMART IMMUNE
Social Links:
Industry:
Biotechnology Health Care
Founded:
2017-07-17
Address:
Paris, Ile-de-France, France
Country:
France
Website Url:
http://www.smart-immune.com
Total Employee:
1+
Status:
Active
Contact:
0033680581505
Email Addresses:
[email protected]
Total Funding:
2.8 M EUR
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Domain Not Resolving Apache Global Site Tag
Similar Organizations
Calimmune
Calimmune is a clinical-stage gene therapy company.
PetMedix
PetMedix is a pet therapeutics startup.
Scholar Rock
Scholar Rock is a biopharmaceutical company that develops and discovers new medicines and treatments for the serious diseases.
Semler Scientific
Semler Scientific is an emerging medical risk-assessment company.
Themis Bioscience
Themis Bioscience is a start-up biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
Sebastian Lombardo
Sebastian Lombardo investment in Seed Round - Smart Immune
Official Site Inspections
http://www.smart-immune.com
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 75.2.70.75
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Smart Immune"
Company Profile - Smart Immune
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered cell therapy platform to fully and rapidly re-arm the immune system, enabling next-generation allogeneic T-cell therapies for all. The …See details»
Smart Immune - Crunchbase Company Profile & Funding
Organization. Smart Immune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. About. Smart …See details»
Executive Team - Smart Immune
Before co-founding Smart Immune, she was the CEO of the French Foundation for Hearing for 3 years and the co-secretary general of the Imagine Institute of Genetic Diseases for 10 years, where she structured, developed, and ensured …See details»
Smart Immune - LinkedIn
Smart Immune | 6,296 followers on LinkedIn. Pioneering thymus-empowered T-cell platform to fight cancer and infection | Smart Immune is a clinical-stage French biotechnology company …See details»
Smart Immune 2025 Company Profile: Valuation, …
How much funding has Smart Immune raised over time? Smart Immune has raised $66.2M. Who are Smart Immune’s investors? Bill & Melinda Gates Foundation, OCA Ventures, European Innovation Council Fund, Pablo Silveri, …See details»
Smart Immune - Funding, Financials, Valuation & Investors
Smart Immune is a biotech company that helps fight against cancer and infection by providing a thymus-empowered T-cell therapy platform. New. Resources. ... How much funding has this …See details»
Smart Immune - healthtechinnovationdays6.com
Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus- empowered T cell progenitor platform to rapidly re-arm the immune system against cancer and …See details»
Smart Immune - Craft
Smart Immune is a biotherapeutics company focused on delivering a hematopoietic stem cell transplantation drug ProTcell to patients in life-threatening conditions. It aims to fight severe …See details»
Smart Immune and CELLforCURE by SEQENS Partner to …
Dec 3, 2024 PRESS RELEASE | Paris, France – December 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and …See details»
Smart Immune Company Overview, Contact Details & Competitors …
Apr 16, 2023 Smart Immune SAS receives financing of $5M in equity investment. Smart Immune SAS, a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T …See details»
Smart Immune - EU-Startups
Smart Immune is a clinical-stage biotechnology company focused on developing the next generation of hematopoietic stem cell-based biotherapies to change prognosis and life quality …See details»
About Us - Smart Immune
At Smart Immune, scientists and clinicians have a keen understanding of T cell and NK differentiation with more than 25 years of experience in hematopoiesis and lymphopoiesis. Of …See details»
Smart Immune and CELLforCURE by SEQENS partner to …
Dec 3, 2024 Smart Immune, a clinical-stage biotechnology company, and CELLforCURE by SEQENS, a Contract Development and Manufacturing Organization (CDMO) for Advanced …See details»
Smart Immune - Contacts, Employees, Board Members
Organization. Smart Immune . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 5. Number of …See details»
Smart Immune receives $5 million investment to further its
Apr 17, 2023 Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T-cell therapy platform to fully and rapidly re-arm the immune system, …See details»
Smart Immune receives €2.5m grant and €15m equity investment …
Mar 30, 2023 Smart Immune is a clinical-stage biotechnology company developing ProTcell, a thymus-empowered T-cell therapy platform to fully and rapidly re-arm the immune system, …See details»
An innovative public-private partnership fueling our …
Feb 14, 2023 Jérôme Larghero: There were three drivers behind this CDMO (Contract development and manufacturing organization) partnership with Smart Immune. First, we have …See details»
Smart Immune Announces FDA Orphan Drug Status, IND …
May 10, 2021 Phase 1/2 Trial to Begin By Fall 2021 at a Top US Cancer CenterPARIS, May 10, 2021 (GLOBE NEWSWIRE) -- Smart Immune SAS, a T cell medicine company utilizing its …See details»
ProTcell Therapy & the Future of Allogeneic Immunotherapy
5 days ago Hi, I’m Olivier Negre, Chief Scientific Officer at Smart Immune since 2020. I now have over 20 years of experience in biotherapy and gene therapy. My journey began working …See details»
Pipeline - Smart Immune
SMART101 is manufactured from peripheral mobilized blood stem cells. It is currently studied in 3 phase I/II clinical trials: - in Europe in patients with severe combined immunodeficiency (SCID) …See details»